Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Dynamic Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: Global

BZ Fine Funds - BZ Fine Pharma

+ Add to Watchlist

BZPHAAF:LX

170.14 CHF 0.67 0.39%

As of 00:59:30 ET on 03/27/2015.

Snapshot for BZ Fine Funds - BZ Fine Pharma (BZPHAAF)

Year To Date: +5.86% 3-Month: +6.70% 3-Year: - 52-Week Range: 129.15 - 177.07
1-Month: +2.57% 1-Year: +25.56% 5-Year: - Beta vs LUXXX: 0.67

Mutual Fund Chart for BZPHAAF

No chart data available.
  • BZPHAAF:LX 170.14
  • 1M
  • 1Y
Interactive BZPHAAF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BZPHAAF

BZ Fine Funds - BZ Fine Pharma is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to achieve appropriate growth. The Fund invests its assets in equities, bonds and other products related to the pharmaceutical industry.

Inception Date: 01-15-2013 Telephone: 352-260248-1 Tel
Managers: ERIC BONVIN
Web Site: www.ipconcept.lu

Fundamentals for BZPHAAF

NAV (on 2015-03-27) 170.14
Assets (M) (on 2015-03-27) 23.14
Fund Leveraged N
Minimum Investment 100.00
Minimum Subsequent Investment -

Dividends for BZPHAAF

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for BZPHAAF

Front Load 2.00
Back Load 2.00
Current Mgmt Fee 1.50
Redemption Fee 2.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BZPHAAF

Filing Date: 06/30/2014
Name Position Value % of Total
Walgreens Boots Alliance Inc 21,200 1,151,785 8.880%
Galenica AG 1,610 1,140,251 8.791%
ICON PLC 27,000 916,563 7.067%
HCA Holdings Inc 19,270 783,148 6.038%
Basilea Pharmaceutica 7,500 647,531 4.992%
Biogen Inc 2,700 629,776 4.856%
Gilead Sciences Inc 10,000 608,109 4.688%
STADA Arzneimittel AG 17,300 602,300 4.644%
Hologic Inc 32,000 600,161 4.627%
UCB SA 9,220 569,980 4.395%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil